1. Wolf SM, Barrows HS. Myasthenia gravis and systemic lupus erythematosus. Arch Neurol. 1966. 14:254–258.
Article
2. Ciaccio M, Parodi A, Rebora A. Myasthenia gravis and lupus erythematosus. Int J Dermatol. 1989. 28:317–320.
Article
3. Alarcon-Segovia D, Galbraith RF, Maldonado JE, Howard FM. Systemic lupus erythematosus following thymectomy for myasthenia gravis: Report of two cases. Lancet. 1963. 2:662–665.
4. Petersen P, Lund J. Systemic lupus erythematosus following thymectomy for myasthenia gravis. Dan Med Bull. 1969. 16:179–181.
5. Kennes B, Delespesse G, Vandenbossche JL, Sternon J. Systemic lupus erythematosus triggered by adult thymectomy in myasthenia gravis patient: report of a case. Acta Clin Belg. 1978. 33:110–116.
Article
6. Abbruzzese G, Abbruzzese M, Bacigalupo A, Ratto S. Systemic lupus erythematosus after thymectomy in a patient with myasthenia gravis. Neurology. 1979. 29:1436–1437.
Article
7. Calabrese LH, Bach JF, Currie T, Vidt D, Clough J, Krakauer RS. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Arch Intern Med. 1981. 141:253–255.
Article
8. Mevorach D, Perrot S, Buchanan NM, Khamashta M, Laoussadi S, Hughes GR, Menkes CJ. Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus. 1995. 4:33–37.
Article
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997. 40:1725.
Article
10. Lewis RA, Selwa JF, Lisak RP. Myasthenia gravis: immunological mechanisms and immunotherapy. Ann Neurol. 1995. 37:Suppl 1. S51–S62.
Article
11. Drachman DB. Myasthenia gravis. N Engl J Med. 1994. 330:1797–1810.
Article
12. Gerli R, Paganelli R, Cossarizza A, Muscat C, Piccolo G, Barbieri D, Mariotti S, Monti D, Bistoni O, Raiola E, Venanzi FM, Bertotto A, Franceschi C. Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol. 1999. 103:865–872.
Article
13. Krakauer RS, Waldmann TA, Strober W. Loss of suppressor T cells in adult NZB/NZW mice. J Exp Med. 1976. 144:662–673.
Article
14. Steinberg AD, Law LD, Talal N. The role of NZB-NZW F1 thymus in experimental tolerance and auto-immunity. Arthritis Rheum. 1970. 13:369–377.
Article
15. Smith HR, Green DR, Smathers PA, Gershon RK, Raveche ES, Steinberg AD. Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin Exp Immunol. 1983. 51:579–586.
16. Souadjian JV, Enriquez P, Silverstein MN, Pepin JM. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med. 1974. 134:374–379.
Article
17. Grinlinton FM, Lynch NM, Hart HH. A pair of monozygotic twins who are concordant for myasthenia gravis but became discordant for systemic lupus erythematosus post-thymectomy. Arthritis Rheum. 1991. 34:916–919.
Article
18. Goldman M, Herode A, Borenstein S, Zanen A. Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis. Arthritis Rheum. 1984. 27:701–703.
Article